UB CAT
The University at Buffalo Center for Advanced Technology in Big Data and Health Sciences (UB CAT) is a project cost-sharing grant program funded by Empire State Development, and designed to drive the growth of life and health science businesses in New York State.
By partnering with a University at Buffalo investigator, New York State companies can access matching funds for collaborative product development or proof of concept research in the health sciences, especially in the areas of drug development, medical devices, diagnostic tools and healthcare IT. Preference will be given to projects that involve or enable Big Data applications.
Health science companies can benefit from: project cost-sharing; outstanding faculty expertise; state-of-the art facilities and equipment; and access to SUNY’s reduced rates on services and supplies.
Eligibility Criteria for Project Funding:
- Proposed projects must align with UB CAT’s focus areas
(big data and health sciences) - Company is registered in NYS and has an office location in NYS
- Company has at least 1 full time employee
- Company has available matching funds for project cost sharing
- Commitment of a University at Buffalo Principal Investigator*
- Scientific, technical, and innovative merit
- Demonstrated need for support of project
- Ability to successfully complete project in one fiscal year
(July-June of the project year) - Potential economic impact for New York State**
- Appropriateness of budget items within UB CAT project guidelines
* All projects are subject to State University of New York intellectual property policies. Click here for special SWIFT for CAT preferred terms.
** Companies that receive CAT funding are required to provide annual economic impact reports for five years. Information on eligible economic impacts and reporting is available upon request.
Current UB CAT Projects:
Current UB CAT projects where faculty and industry have partnered for 2019-2020:
Jun Qu, PhD
Epigenetic drug discovery platform for methylation inhibitors
Yun Wu, PhD
Development of novel therapeutic IpY for ER/PR+, HER2- breast cancer: optimizing nanoparticle delivery and leveraging big data for precision treatment
Randall Rasmusson, PhD
Big Data approaches to identifying arrhythmogenic properties
Albert Titus, PhD
Wireless biosensor system advancement project
Jianxin Wang, PhD
Design of parallel-computing platform to develop a multi-scale, physiological-based, drug-disease model for therapeutic monoclonal antibodies targeting inflammatory cytokine mediators involved in the pathogenesis of eosinophilic asthma
Bruce Davidson, PhD
Differential imaging for lung cancer diagnosis
Albert Titus, PhD
Integrated pH sensor for smart wound care
Mark Ehrensberger, PhD
Live microbe imaging of antimicrobial electrical stimulation; Electrical stimulation effects on osseointegration
Immune Modulatory Therapies
Richard Bankert, VMD, PhD
Development and implementation of analytic methods and modeling of big datasets for certain proprietary small molecules in cancer immunotherapy
Timothy Murphy, MD
Biomarker for early diagnosis of prostate cancer
Neurovascular Diagnostics
John Kolega, PhD
Development of whole blood RNA expression-based assay for detecting unruptured brain aneurysms
Praveen Arany, DDS, PhD
Preclinical optimization and clinical testing of novel oral health products
Jonathan Lovell, PhD
Assessing SNAP liposomes for cancer neoantigen screening
Pro Al Medico
Brian R. Weil, PhD
T3np neuroprotection following cardiac arrest; T3np in cardiac resuscitation – pivotal pre-clinical trial
Rheonix
Michael Buck, PhD
Automated DNA library prep for NGS
Veronomics
Jianxin Wang, PhD
Genomics/bioinformatics platforms to identify cancer drugs
APPLY FOR FUNDING
The review of applications for the July 1, 2020 – June 30, 2021 funding period is complete. We are not currently accepting more applications.
Any questions? Email a UB CAT program expert.